|
시장보고서
상품코드
2052488
리드리스 페이스메이커 시장 : 제품 유형별, 종류별, 최종사용자별, 지역별Leadless Pacemakers Market, By Product Type, By Type, By End User, By Geography |
||||||
리드리스 페이스메이커 시장은 2026년에 9억 1,510만 달러로 추정되며, 2033년까지 22억 6,180만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 13.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 9억 1,510만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 13.80% | 2033년 시장 규모 예측: | 22억 6,180만 달러 |
리드리스 페이스메이커는 가슴을 절개하지 않고 허벅지나 경피적 접근 경로를 통해 심장에 이식하는 첨단 심장 박동기로, 심장에 이식하는 방식입니다. 심박조율기에서 심장으로 전선을 연장하여 가슴의 피하로 이식하는 기존 페이스메이커와 달리, 리드리스 페이스메이커는 심장에 직접 이식되어 전선이 없습니다. 이는 페이스메이커 리드와 관련된 합병증 감소, 환자의 자기공명영상(MRI) 검사와의 호환성 향상 등의 이점이 있습니다. 전자기기의 소형화 및 배터리 수명이 향상됨에 따라 서맥 치료에서 리드리스 페이스메이커의 인기가 높아지고 있습니다. 향후 몇 년 동안, 그 세계 수요는 크게 확대될 것으로 예상됩니다.
시장 역학
전 세계 리드리스 페이스메이커 시장은 심혈관질환에 취약한 고령 인구의 증가, 박동기 시스템의 소형화를 가능하게 하는 기술 발전, 합병증 감소 및 자기공명영상(MRI)과의 호환성 등 기존 박동기 대비 리드리스 페이스메이커 시스템의 장점에 의해 주도되고 있습니다. 그러나 기존 심박조율기에 비해 높은 비용과 배터리 수명에 대한 문제가 시장을 억제하는 요인으로 작용하고 있습니다. 각 업체들이 배터리 수명을 개선한 완전 리드리스 페이스메이커 시스템을 도입하는 것은 큰 성장 기회가 될 것입니다. 지역별로는 현재 북미와 유럽의 선진국 시장이 시장을 독점하고 있지만, 향후 몇 년 동안 아시아태평양의 신흥국들이 높은 성장 기회를 가져올 것으로 예상됩니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 리드리스 페이스메이커 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 리드리스 페이스메이커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 리드리스 페이스메이커 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 리드리스 페이스메이커 시장 : 제품 유형별, 2021-2033년
제5장 세계의 리드리스 페이스메이커 시장 : 유형별, 2021-2033년
제6장 세계의 리드리스 페이스메이커 시장 : 최종사용자별, 2021-2033년
제7장 세계의 리드리스 페이스메이커 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSMLeadless Pacemakers Market is estimated to be valued at USD 915.1 Mn in 2026 and is expected to reach USD 2,261.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 915.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.80% | 2033 Value Projection: | USD 2,261.8 Mn |
Leadless pacemakers are advanced cardiac pacemakers that are implanted via femoral or trans-cutaneous access in the heart rather than through incisions in the chest. Unlike traditional pacemakers that are implanted under the skin in the chest with wires running from the pacemaker to the heart, leadless pacemakers are directly implanted in the heart and have no wires. They offer advantages such as reducing complications related to pacemaker leads and enabling more compatibility with magnetic resonance imaging (MRI) scans for patients. With advancements in miniaturization of electronics and improvements in battery life, leadless pacemakers are increasingly gaining popularity for treatment of bradycardia. Their global demand is projected to grow substantially in the coming years.
Market Dynamics
The global leadless pacemakers market is driven by rising geriatric population worldwide that is susceptible to cardiovascular diseases, technological advancements enabling miniaturization of pacemaker systems, and benefits offered by leadless systems over traditional pacemakers such as reducing complications and enabling Magnetic Resonance Imaging, MRI compatibility. However, high cost of leadless pacemakers compared to traditional ones and issues regarding battery longevity act as restraints for the market. Introduction of completely leadless pacing systems with improved battery life by players presents a major growth opportunity. Regionally, developed markets in North America and Europe currently dominate the market but emerging countries in Asia Pacific are expected to provide high growth opportunities in the coming years.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global leadless pacemakers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, EBR Systems Inc., MicroPort Scientific Corporation, Biotronik SE & Co. KG, St. Jude Medical (now part of Abbott), Osypka AG, Lepu Medical Technology, Cardiac Rhythm Management (CRM), AtriCure Inc., Cook Medical, Sorin Group, Biotronik, and Neovasc Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global leadless pacemakers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leadless pacemakers market.
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Micra Transcatheter Pacing System
- Nanostim Leadless Pacemaker
- Other Leadless Pacemakers
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Single Chamber
- Dual Chamber
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- long-term care facilities
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- EBR Systems Inc.
- MicroPort Scientific Corporation
- Biotronik SE & Co. KG
- Jude Medical (now part of Abbott)
- Osypka AG
- Lepu Medical Technology
- Cardiac Rhythm Management (CRM)
- AtriCure Inc.
- Cook Medical
- Sorin Group
- Biotronik
- Neovasc Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Leadless Pacemakers Market, By Product Type
- Global Leadless Pacemakers Market, By Type
- Global Leadless Pacemakers Market, By End User
- Global Leadless Pacemakers Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Leadless Pacemakers Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Micra Transcatheter Pacing System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Nanostim Leadless Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Other Leadless Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Leadless Pacemakers Market, By Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Single Chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Dual Chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Leadless Pacemakers Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- long-term care facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Leadless Pacemakers Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EBR Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jude Medical (now part of Abbott)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Osypka AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lepu Medical Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardiac Rhythm Management (CRM)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AtriCure Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sorin Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neovasc Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
